Application of comorbidity indexes at baseline could be useful to predict rates of response in patients with chronic myeloid leukemia treated with imatinib. Issue 1 (January 2014) - Breccia, Massimo; Salaroli, Adriano; Serrao, Alessandra; Zacheo, Irene; Saracino, Roberta; Alimena, Giuliana